text_1: CD44v6 is not associated with constitutive and reprogrammed cancer stem cells driving cancer metastasis.
text_2: CD44v6(-) progenitor cells do not give rise to metastatic lesions but, when treated with cytokines, acquire CD44v6 expression and metastatic capacity.